Ozempic and Wegovy could double as kidney disease treatment, study suggests

Ozempic could help treat kidney disease patients, new study finds

***Watch previous Ozempic coverage above.*** (WJW) - A popular medication commonly used to treat diabetes and for weight loss can also help patients with chronic kidney disease, according to a recent study. The study, led by researchers at the University of New South Wales Sydney, found that the semaglutide drug, better known by brand names Ozempic and Wegovy, can help prevent kidney failure and death in type 2 diabetics and kidney disease patie…

Ozempic and Wegovy could double as kidney disease treatment, study suggests

Semaglutide medications including Ozempic and Wegovy have been shown to reduce kidney failure risk and the risk of death among people with kidney disease and type 2 diabetes. Two doctors weighed in.

Ozempic Cuts Risk of Death from Kidney Disease, Major Study Finds

The active compound in the best-selling drug Ozempic markedly lowers the risk of complications from chronic kidney disease, according to a multiyear study published Friday - a finding that could dramatically expand the pool of patients eligible for the injections.

Ozempic cuts kidney-disease risks, research finds

Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday.

Semaglutide use tied to lower kidney disease risk in obesity

Data from a new clinical trial suggest that people with obesity and cardiovascular disease who use semaglutide drugs, such as Ozempic and Wegovy, have a lower risk of adverse events related to kidney health.

Ozempic cuts risk of chronic kidney disease complications, study finds - Hawaii Tribune-Herald

Semaglutide, the compound in the blockbuster drugs Ozempic and Wegovy, dramatically reduced the risk of kidney complications, heart issues and death in people with Type 2 diabetes and chronic kidney disease in a major clinical trial, the results of which were published Friday. The findings could transform how doctors treat some of the sickest patients with chronic kidney disease, which affects more than 1 in 7 adults in the United States but has…